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Thyroid hormones are required for human brain develop-
ment, but data on local regulation are limited. We describe the
ontogenic changes in T4, T3, and rT3 and in the activities of the
types I, II, and III iodothyronine deiodinases (D1, D2, and D3)
in different brain regions in normal fetuses (13–20 wk post-
menstrual age) and premature infants (24–42 wk postmen-
strual age). D1 activity was undetectable.
The developmental changes in the concentrations of the
iodothyronines and D2 and D3 activities showed spatial and
temporal specificity but with divergence in the cerebral cor-
tex and cerebellum. T3 increased in the cortex between 13 and
20 wk to levels higher than adults, unexpected given the low
circulating T3. Considerable D2 activity was found in the cor-
tex, which correlated positively with T4 (r  0.65). Cortex D3
activity was very low, as was D3 activity in germinal eminence
and choroid plexus. In contrast, cerebellar T3 was very low
and increased only after midgestation. Cerebellum D3 activ-
ities were the highest (64 fmol/minmg) of the regions studied,
decreasing after midgestation. Other regions with high D3
activities (midbrain, basal ganglia, brain stem, spinal cord,
hippocampus) also had low T3 until D3 started decreasing
after midgestation. D3 was correlated with T3 (r0.682) and
rT3/T3 (r  0.812) and rT3/T4 (r  0.889).
Our data support the hypothesis that T3 is required by the
human cerebral cortex before midgestation, when mother is
the only source of T4. D2 and D3 play important roles in the
local bioavailability of T3. T3 is produced from T4 by D2, and
D3 protects brain regions from excessive T3 until differenti-
ation is required. (J Clin Endocrinol Metab 89: 3117–3128,
2004)
THYROID HORMONE IS necessary for normal brain de-velopment. It becomes increasingly clear that the levels
of thyroid hormones required at different stages of devel-
opment are critical. Conditions relating thyroid hormones to
poor brain development have recently been summarized in
a review by Morreale de Escobar et al. (1). For instance,
congenital hypothyroidism leads to severe mental retarda-
tion if it remains untreated. Maternal hypothyroxinemia
caused by marked iodine deficiency during the first half of
pregnancy is also causally related to neurological cretinism
(2) and a decreased mental development of a large propor-
tion of the noncretin population (3). Even undiagnosed early
maternal hypothyroxinemia (4, 5) or hypothyroidism (6) has
been suggested to adversely affect neurological development
of the child. Not only maternal and/or fetal and neonatal
hypothyroidism clearly affect brain development, but also
excessive levels of thyroid hormones may lead to abnormal
brain development (7).
Nuclear thyroid hormone receptors have been demon-
strated in the brain from wk 10 (8). In the first trimester, the
fetus is solely dependent on maternal thyroid hormones,
which cross the human placenta (9–11). From midgestation,
secretion of thyroid hormone by the fetal thyroid becomes
increasingly important (12), although the maternal contri-
bution of thyroid hormone persists until birth (13) and may
still play a critical role in the preferential protection of the
fetal brain from T3 deficiency (11). Serum T3 levels are very
low during fetal development, ranging from less than 33
ng/dl (0.5 nm) at 13 wk postmenstrual age (PMA) (14) up to
approximately 65 ng/dl (1.0 nm) at term (15). Despite these
very low serum concentrations, Bernal and Pekonen (8) and
Bernal and colleagues (16, 17) measured T3 in several fetal
tissues between 13 and 18 wk PMA. Their studies showed
that the concentration of T3 in the fetal cortex at 13 wk PMA
may actually reach 50–60% of the values reported for adults
(18), with 20–30% nuclear receptor occupancy. The concen-
trations both of the nuclear receptors and total T3 in the
cerebral cortex continue to increase rapidly up to 18 wk
gestation. This does not occur during the same developmen-
tal period in other fetal tissues, such as the lung and liver, and
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there is no information for brain areas other than the cortex.
The T3 levels of the human fetal cortex are much higher than
would be expected from the serum T3 levels, a finding that
may be explained by the active transport of thyroid hormone
through the plasma membrane, the difference in intracellular
vs. extracellular thyroid hormone-protein binding, and
mainly by local deiodination of iodothyronines (19, 20).
Deiodination is catalyzed by three deiodinases, i.e. types
I, II, and III deiodinase (D1, D2, and D3). D1 is mainly
expressed in the liver, kidney, and thyroid. Its main function
is the production of serum T3 and the clearance of serum rT3
(20–22). D1 is not expressed in cells of the central nervous
system. D2 is present in brain, pituitary, brown adipose
tissue, human thyroid, and skeletal muscle (20, 23–25). It
catalyzes the outer ring deiodination of T4 to T3 and is thus
important for the local production of T3. D2 expression in the
different tissues is down-regulated in hyperthyroidism and
up-regulated in hypothyroidism (23). In the rat, D2 has been
demonstrated in astrocytes throughout the brain, in the me-
dian eminence and tanycytes lining the third ventricle (26,
27). D3 catalyzes the inner ring deiodination of T4 to rT3 and
of T3 to 3,3-T2 (20–22). It is expressed in brain, skin, fetal
tissues, placenta, and uterus and at other sites of the mater-
nal-fetal interface, such as the umbilical arteries and vein
(28–33). Brain D3 activity is up-regulated in hyperthyroid-
ism and down-regulated in hypothyroidism. D3 is predom-
inantly present in neuronal cells (34, 35), which are the main
cells that express thyroid hormone receptors (36, 37). It has
been hypothesized (38, 39) that T4 is taken up from the blood
by glial cells and converted to T3 in these cells. Subsequently,
depending on the type of glial cells in which this has oc-
curred, T3 would be released from astrocytes to neurons by
a paracrine route, whereas the T3 generated in the tanycytes
could be secreted into the cerebrospinal fluid and from there
reach neural cells. Once T3 reaches neurons, it would be
available to the thyroid hormone receptors and exert its
effects. The D3 expressed in the neurons would limit T3
bioavailability for receptor binding. In such a model, a close
ontogenic regulation of brain D2 and D3 expression seems
crucial for providing T3 to the brain in the amounts needed
in different structures at different stages of development.
Different regions of the brain have specific temporal pat-
terns of development, and thus may require a different reg-
ulation of T3 bioavailability. Figure 1 shows the human brain
roughly subdivided into different regions. Table 1 summa-
rizes the main function of these regions in the adult brain
(40). To study the importance of local control of T3 synthesis
and degradation for human brain development, we deter-
mined deiodinase activities (D1, D2, and D3) as well as T3,
T4, and rT3 concentrations in the brain regions shown in Fig.
1 at different stages of development.
Materials and Methods
Tissue samples
Brains were obtained from 28 fetuses of 13–20 wk PMA at termination
of uncomplicated pregnancies for psychosocial reasons. Fetal tissue was
collected within 1 h after termination of pregnancy using Misoprostol
(Roussel, Uxbridge, UK) vaginal pessaries. Fetal developmental age was
carefully estimated solely by one of us (R.H.) based on size, including
crown-heel, crown-rump, and heel-toe measurements (41); menstrual
history; and ultrasound dating of pregnancy. Normality of fetuses was
confirmed by autopsy. Fetal lung organ cultures were routinely estab-
lished as an indicator of tissue quality. Only tissues from fetuses in which
lung airways dilated and the lining epithelium autodifferentiated in
culture were used (42). Pregnancies were terminated in accord with the
Abortion Act 1967 (United Kingdom) and fetal samples and data han-
dled according to the recommendations of the United Kingdom Gov-
ernment: Review of the guidance on the research use of fetuses and fetal
material (Polkinghorne Report) 1989 HMSO. The study was approved
by the Multicenter Research Ethics Committee (Edinburgh), the Tayside
Committee on Medical Research Ethics, and the Yorkhill Local Research
Ethics Committee. In all cases written informed consent was obtained.
The fetal brain samples were divided into two PMA age-matched
groups, one of which was sent to the Rotterdam laboratory and the other
to Madrid.
Brains were also available from nine premature infants who were
born at 23–33 wk PMA and died between 24 and 42 wk PMA with
FIG. 1. Cartoon roughly illustrating the
different areas from which brain samples
were obtained. In fetuses, cortex samples
were obtained from the region separating
the two hemispheres (medial cortex) and
the parietal region (lateral cortex). The CP
used in the present study was that of the
lateral ventricles. GE samples were no
longer available after 28 wk PMA, whereas
samples of the H were obtained only from
the premature infants. Samples from the
MB were obtained up to 20 wk PMA, after
which the BG could be identified and dis-
sected out.
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postnatal ages of 3 min to 15 wk (Table 2). Parental authorization for
postmortem examinations including full organ histology and ancillary
investigations was obtained, and examinations were performed by a
pediatric pathologist (A.H.). The major postmortem findings and diag-
noses are given in Table 2. The samples from each hemisphere of the
brains of the premature infants were frozen separately for shipment to
the Madrid and Rotterdam laboratories. The tissues were divided and
frozen in liquid nitrogen and stored at 80 C until use.
Different areas from fetal and premature infants’ brains were dis-
sected fresh and snap frozen immediately: choroid plexus (CP), medial
and lateral cerebral cortex (CC), germinal eminence (GE), cerebellum
(Cbl), brain stem (BS), spinal cord (SC), midbrain (MB), basal ganglia
(BG), and hippocampus (H), as illustrated in Fig. 1. Exact dissection of
the fetal brain areas was done as follows. The fetal brain was exposed
by partial removal of the calvaria after incisions were made through the
lambdoid, sagittal, and metopic sutures. In the now partially exposed
fetal brain, a longitudinal incision was made through the superior aspect
of the left CC, and this was extended into the lateral ventricle. The lateral
ventricle CP was lifted out, exposing the tissue ridge of the GE, which
was removed by careful dissection. The tissue between the ventricular
wall and the surface of the CC on the medial and lateral aspects was
removed, thereafter called the medial and lateral CC. A similar dissec-
tion procedure was carried out on the right cerebral hemisphere and the
tissue retained. The remaining cerebral cortical tissue was then removed,
exposing the superior aspect of the MB region. A horizontal incision was
made just superior to the upper border of the Cbl to define the superior
border of the BS and the inferior aspect of the MB region, which was then
dissected free. The fourth ventricle CP was carefully lifted free, and the
cerebellar hemispheres dissected from the BS tissue. The inferior border
of the BS was defined as the level of the pyramidal decussation. The
entire SC was removed by dissection and retained. In all brain regions
the pia-arachnoid membrane was removed.
The nine premature brains available for sampling ranged from 23 to
33 wk. At these stages of development, readily identifiable landmarks
and anatomical relationships allowed accurate sampling of brain areas
of interest. The Cbl and BS were detached from the upper MB by a
transverse incision. The brain was subjected to coronal sectioning, with
the first incision made at the level of the mamillary bodies, and if these
were not readily identified, the incision was made immediately behind
the optic chiasma. Serial coronal sections, at intervals of 0.5 cm, were
then performed. The coronal sections of brain were then examined to
permit accurate orientation for sampling. The medial cortical sample
represented a block of cortex lining the interhemispheric sulcus between
the cerebral hemispheres. This cortical sample was made to a maximum
depth of 1 cm. The lateral cortical sample was of similar depth and was
from the parietal cortex. CP was taken from the lateral ventricles. The
BG mass was identifiable adjacent to and below the lateral ventricles.
The GE was identifiable in the cases between 24 and 27 wk gestation as
TABLE 2. Medical histories of premature infants




Extreme prematurity Emergency lower uterine segment cesarean section
(LUSCS); hepatomegaly with cholestasis, focal
myocardial ischemic injury, Candida albicans
septicemia
580 23 26 22 d F
Extreme prematurity Normal pregnancy until assisted breech delivery 655 24 24 3 min M
Extreme prematurity Twin transfusion syndrome; sac with polyhydram-
nios
527 24 24 70 min M
Extreme prematurity Twin transfusion syndrome; mild pulmonary hyp-
oplasia; sac with oligohydramnios; twin of baby 3
569 24 24 122 min M
Extreme prematurity Pseudomonas aeruginosa septicemia, endocarditis,
intraventricular hemorrhage
740 26 27 8 d F
Extreme prematurity Bronchopneumonia (P. aeruginosa); twin of baby 5 590 26 27 8 d F
Complications of prematu-
rity
Intraventricular hemorrhage, necrotizing enterocoli-
tis, bronchopulmonary dysplasia, pulmonary hy-
pertension, recurrent sepsis; cerebellar hypoplasia
840 27 42 15 wk M
Hydrops fetalis (congenital
heart anomaly)
Emergency LUSCS at 31 wk; ventilator dependent
throughout life
1970 31 33 15 d F
Congenital cardiac anomaly Hyaline membrane disease 1877 33 33 13 h M
F, Female; M, male.
TABLE 1. Functions of the different brain regions in adults (40)
Region Function
SC Controls movement of the limbs and the trunk; receives and processes sensory information
from the skin, joints, and muscles of the limbs and trunk
BS Receives sensory information from and provides motor output to head, face, neck, and eyes
and receives information from special senses as hearing, balance, and taste. In addition,
conveys information from the brain to the SC and vice versa
MB Controls many sensory and motor functions, including eye movement and coordination of
visual and auditory reflexes
Cbl Modulates the force and range of movements and is involved in the learning of motor skills
CC Is involved in cognitive functions such as language
BG Participates in regulating motor performance
H Is involved in memory storage
GE Fetal brain structure from which cortical interneurons migrate; this brain structure
disappears during late fetal brain development
CP Secretes cerebral spinal fluid, maintains chemical stability of the central nervous system
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a subependymal protuberance over the head of the caudate nucleus on
the lateral wall of the lateral ventricle. The H was identified as a gyral
structure seen in the coronal section taken immediately posterior to the
aqueduct identified in the cut surface of the MB. Cbl, BS, and SC samples
were taken from these readily identifiable structures. The BS samples
comprise lower pons and medulla.
Materials
[3-125I]T3 was obtained from Amersham (Amersham, UK) for the
determination of D3; T4, T3, rT3, and 3,3-T2 were purchased from Hen-
ning Berlin GmbH (Berlin, Germany). High specific activity [3,5-131I]T4,
[3,5-125I]T4, [3-
125I]T3, and [3,5-
125I]rT3 (3000 Ci/g) were pre-
pared by radioiodination of T3, 3,5-T2, and 3,3-T2, respectively, as pre-
viously described (43), and used for the determinations of T4, T3, and rT3
concentrations and D2 activities. [3,5-125I]T3 was obtained from Formula
GmbH (Berlin, Germany). Dithiothreitol (DTT) and 6-n-propyl-2-thio-
uracil (PTU) were obtained from Sigma (St. Louis, MO); Sephadex LH-20
from Pharmacia (Woerden, The Netherlands); and Dowex-50W-X2 and
AG 1  2 resins from Bio-Rad Laboratories (Richmond, CA).
Determination of T4, T3, and rT3 concentrations in human
fetal brain
T4, T3, and rT3 were determined by highly sensitive and specific RIAs
after extensive extraction and purification of the iodothyronines from
tissues, as described elsewhere (43, 44). In brief, the sample was ho-
mogenized directly in methanol, and [131I]T4 and [
125I]T3 were added to
each sample as internal tracers for recovery calculations. These tracers
were added in amounts small enough to avoid interferences in the final
RIAs. Appropriate volumes of chloroform were added to extract with
chloroform/methanol (2:1), twice. The iodothyronines were then back-
extracted into an aqueous phase and purified by passing this aqueous
phase through Bio-Rad AG 1  2 resin columns. After a pH gradient,
the iodothyronines were eluted with 70% acetic acid, which was then
evaporated to dryness and the residue dissolved in RIA buffer. Each
extract was extensively counted to determine the recovery of the [131I]T4
and [125I]T3 added to each sample during the initial homogenization
process. Average recovery was 50–60% for [131I]T4 and 60–70% for
[125I]T3. T4 and T3 contents were determined by RIAs in triplicate at two
dilutions. For the determination of rT3, we used the same procedure as
for T4 and T3 but using [
125I]rT3 as recovery tracer. The limits of detection
are 3.3 fmol T4, 1.1 fmol T3, and 1.5 fmol rT3/tube. The molar cross-
reactivities for the RIAs and the inter- and intraassay variations (10%)
have been previously described (10, 14, 45, 46). Concentrations were then
calculated using the amounts of T4 and T3 found in the respective RlAs,
the individual recovery of the [131I]T4 and [
125I]T3 added to each sample
during the initial homogenization process, and the weight of the tissue
sample submitted to extraction. The results are given throughout in
picomoles per gram wet weight.
No corrections for the amounts iodothyronines contributed by the
blood trapped in the tissue aliquot could be carried out due to lack of
blood or serum from the fetuses or premature infants studied.
Determination of D1 and D3 activity
Tissues were homogenized on ice in 5 volumes 0.1 m phosphate (pH
7.2), 2 mm EDTA, containing 1 mm DTT, using a Polytron (Kinematica,
Lucerne, Switzerland). The tissue homogenates were stored at 80 C
until further analysis. Protein concentrations were determined using the
method of Bradford (47), using BSA as standard.
D1 activities were determined by incubation of 0.1 m [125I]rT3
(100,000 cpm) for 60 min at 37 C with 1 mg protein/ml tissue homog-
enate in the presence or absence of 0.1 mm PTU in 0.1 ml 0.1 m phosphate
(pH 7.2), 2 mm EDTA, 10 mm DTT. Reactions were stopped by the
addition of 0.1 ml 5% BSA. Protein-bound [125I]iodothyronines were
precipitated by addition of 0.5 ml 10% trichloroacetic acid. After cen-
trifugation, the supernatants were analyzed for 125I production on
Sephadex LH-20 minicolumns (bed volume 0.25 ml), equilibrated, and
eluted with 0.1 m HCl.
D3 activities were measured in the Rotterdam laboratory by incu-
bation of 1 nm [125I]T3 (200,000 cpm) for 60 min at 37 C with 0.05 or 1
mg protein/ml tissue homogenate in 0.1 ml 0.1 m phosphate buffer (pH
7.2), 2 mm EDTA, and 50 mm DTT. Reactions were stopped by the
addition of 0.1 ml ice-cold methanol. After centrifugation, 0.15 ml su-
pernatant was mixed with 0.1 ml 0.02 m ammonium acetate (pH 4.0), and
0.1 ml of the mixture was applied to a 4.6  250 mm Symmetry C18
column connected to an Alliance HPLC system (Waters, Etten-Leur, The
Netherlands), and eluted with a gradient of acetonitrile in 0.02 m am-
monium acetate (pH 4.0) at a flow of 1.2 ml/min. The proportion of
acetonitrile was increased linearly from 30 to 44% in 10 min. The ra-
dioactivity in the eluate was determined using a Radiomatic A-500 flow
scintillation detector (Packard, Meriden, CT). D3 activities are expressed
in femtomoles per minute per milligram protein.
D3 activities in a smaller number of samples were also determined in
the Madrid laboratory by measuring the iodide released after incubation
of tissue homogenates with 40,000 cpm of inner-ring labeled [3,5-125I]T3
(80 Ci/g) at 37 C during 1 h. Assay final conditions were 25 nm T3,
20 mm DTT, 1 mm PTU (pH 7.5), and 40–50 g protein in a total volume
of 100 l. [125I]iodide was separated from the rest of the reaction prod-
ucts using Dowex 50W X2 columns as described (48). The amount of
iodide in the blanks was routinely less than 0.5% of the total radioac-
tivity. Detection limits were 1.2–1.7 fmol/minmg protein.
Determination of D2 activity
Brain samples were homogenized in buffer [0.32 m sucrose, 10 mm
HEPES, and 10 mm DTT (pH 7.0)]. Before each assay [125I]T4 was purified
by paper electrophoresis from contaminating iodide. D2 activity was
assayed as previously described (49), incubating 80–100 g protein with
80,000 cpm of [125I]T4, 2 nm T4, 1 m T3, 20 mm DTT, and 1 mm PTU for
1 h at 37 C. The total volume was 100 l. The 125Iodide released was
separated by ion-exchange chromatography on Dowex-5OW-X2 col-
umns equilibrated in 10% acetic acid. The amount of iodide in the blanks
was routinely less than 1% of the total radioactivity. Results were ex-
pressed in femtomoles per hour per milligram protein. Detection limits
were 2–5 fmol/hmg protein.
Statistical analysis
Unless data points are shown individually, results are given as
means  se. These values, significance of differences between means
(Student’s t test), and Pearson’s correlation coefficients, bivariate or
partial (correcting for PMA), were calculated using the SPSS statistical
package (SPSS Inc., Chicago, IL). P  0.05 was considered significant.
The regression coefficients r and P values shown in some panels of the
figures (see Figs. 2, 3, 4, and 6) were calculated with the SPSS statistical
package for curve estimation regression analysis, which evaluates the
degree of fitting of the different variables (iodothyronine concentrations,
T3/T4 ratios, D2 activities, etc.) as different functions of PMA. Eleven
different functions were tested (linear, logarithmic, inverse, quadratic,
cubic, power, compound, logistic, growth, exponential, S mode). Only
when P  0.05, the regression coefficients from the curve estimation
analysis are shown in the corresponding panels, the type of function
being indicated in the figure legend. Curves through data points shown
in the same panels were obtained using the options provided by CA-
Cricket Graph III for MacIntosh (Computer Associates International,
Inc., Plaza Islandia, NY) for the type of function disclosed by the curve
estimation regression analysis.
Results
Figure 2 shows the changes with increasing PMA of the
concentrations of T4, T3, and rT3 in different regions of the
brain between 13 and 20 wk PMA. There were no statistically
significant differences in the iodothyronine concentrations
between medial vs. lateral cortex, and data were pooled as
CC. Major differences are seen between some of the patterns
corresponding to different brain areas. Thus, the T4 concen-
trations were fitted to a quadratic function of PMA in the
cortex, GE, and CP, with positive values of the coefficient r.
The changes in T4 vs. PMA in the Cbl also fitted a quadratic
function of PMA, but it was a distinctly different one, con-
sidering the regression coefficient r is negative. The concen-
3120 J Clin Endocrinol Metab, July 2004, 89(7):3117–3128 Kester et al. • Iodothyronine Deiodination in Human Developing Brain
 by on May 21, 2010 jcem.endojournals.orgDownloaded from 
FIG. 3. Concentrations of T4, T3, and rT3 (in picomoles per gram wet weight) in different areas of the brain of premature infants, as a function
of their PMA at death (see Table 2), shown in continuation of data points (within the shaded insets) that correspond to the fetal samples of Fig.
2. To convert values for T4 to nanograms per gram, divide by 1.287; to convert values for T3 and rT3 to nanograms per gram, divide by 1.54.
For the meaning of the r and P values, see the legend to Fig. 2. They correspond to quadratic functions of PMA in all panels where r and P
values are shown, except for CP T4, CC, and BG T3, and BS rT3, which were cubic functions of PMA.
FIG. 2. Ontogenic changes of the concentrations of T4, T3, and rT3 (in picomoles per gram wet weight), up to 20 wk PMA. To convert values
for T4 to nanograms per gram, divide by 1.287; to convert values for T3 and rT3 to nanograms per gram, divide by 1.54. The ordinate scales
shown on the left axis are the same for all areas, with the exception of the CP, for which they are shown on the right-hand axis. In this and
further figures, the regression coefficients r and the P values shown in the panels are those corresponding to the functions calculated by curve
estimation regression analysis (as outlined in Materials and Methods). No r values are shown if P  0.05. T4 concentrations were fitted to a
quadratic function of PMA in the cortex, GE, SC, CP, and Cbl, with positive regression coefficients. In contrast, it is negative for the Cbl. The
concentrations of T3 in the cortex and SC increased significantly with PMA, following a quadratic function but not in other areas, including
the CP, despite the striking increase of the concentrations of T4 in the latter area. The concentrations of rT3 decreased linearly in the cortex
and BS with increasing PMA.
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tration of T3 in the cortex and SC increased significantly with
PMA, following quadratic functions, but not in the other
areas, including the CP, despite the striking increase of the
concentrations of T4 in this area. The concentrations of rT3
decreased linearly in the cortex and BS and tended to de-
crease in the GE and MB (not statistically significant).
The observed changes during this intrauterine period rep-
resent ontogenic profiles because the fetuses and their moth-
ers were presumably normal. This may not be so for the data
obtained from the brains of the premature infants because the
illnesses suffered and the different causes of their death
might affect the observed profiles. For this reason they are
shown separately in Fig. 3 as a continuation of the data of the
fetuses, and are referred to the PMA at death, to follow the
same criterion as used for Fig. 2.
It appears that T4 concentrations continue to increase in
most areas, following quadratic or cubic functions of PMA
(Fig. 3). T3 concentrations also start increasing in areas in
which they hardly changed before 20 wk PMA or in which
they had actually been decreasing in fetuses (Cbl). The con-
centrations of rT3 increase in the BS, in which they had been
decreasing before 20 wk PMA, with no well-defined patterns
of change being found in the remaining areas. In the H (not
shown in Fig. 3), obtained only from the premature infants,
no correlations were found with PMA at death, mean values
being 3.54  0.49 pmol T4/g (2.75  0.38 ng T4/g, n  9),
1.35  0.50 pmol T3/g (0.879  0.33 ng T3/g, n  9), and
1.98 0.57 pmol rT3/g (1.289 0.37 ng rT3/g, n 9). When
data from all brain areas obtained between 13 and 42 wk
PMA are considered as a whole, positive correlations were
found vs. age for the three iodothyronines, with P 0.003 for
T4 and P  0.001 for T3 and rT3. Considering the data of the
fetuses alone, the positive correlation for rT3 was lost. When
the premature babies alone were considered, only the pos-
itive correlation for T3 persisted (P  0.001).
Tissue iodothyronine levels depend on not only local io-
dothyronine deiodinase activities but also, among others, on
the supply of thyroid hormone, in particular T4, from the
circulation. As a means to correct for changes in T4 supply,
the T3/T4, rT3/T4, and rT3/T3 ratios were calculated and
plotted against PMA. Some correlations between the ratios
and PMA were found. Thus, for instance, the T3/T4 ratio
increased throughout the study period in the CC (r  0.482;
P  0.005), whereas it tended to decrease in the GE (r 
0.473; P 0.053). The rT3/T4 ratio decreased in the CC, but
only in fetuses (r  0.721; P  0.001), and increased in the
same area in premature infants (r  0.669; P  0.049). It
decreased throughout the study period in the GE (r0.807;
P 0.001) and CP (r0.485; P 0.048). The rT3/T3 ratios
showed changes similar to those of the rT3/T4 ratios in the
CC of the fetuses (r0.861; P 0.001) and also decreased
in the CP (r0.804; P 0.001) throughout the study period
and in the BG of the premature infants (r  0.620; P 
0.024). The changes with PMA of these ratios in the human
developing brain and of the concentrations of the iodothy-
ronines shown in Figs. 2 and 3 clearly suggest that patterns
are both area and age specific.
Therefore, they cannot be predicted from the circulating
levels of the iodothyronines at different stages of develop-
ment. This point is illustrated in Fig. 4, in which the T3/T4
ratios in the CP, GE, and CC up to 20 wk PMA are compared
with those obtained in sera from developing fetuses. The
latter are taken from a previous study (14), in which the same
analytical procedures had been used as for the present brain
areas, thus permitting the determination of the very low
concentrations of T3 in fetal serum. The T3/T4 ratios in serum
tended to decrease with PMA, but the regression coefficient
did not reach statistical significance. In the GE and CP, the
T3/T4 ratios decrease linearly with PMA. In contrast, the
T3/T4 ratio in the CC increased with PMA.
In addition to the iodothyronine levels, deiodinase activ-
ities were determined in the human developing brain sam-
ples. No detectable D1 activity was found in any brain sam-
ple (data not shown). D2 and D3 activities were determined
in the Cbl, BS, SC, CP, and CC from both fetal and premature
infants’ samples (13–42 wk PMA), MB and GE from fetal
samples (13–20 wk PMA), and BG and H from premature
infants (23–42 wk PMA at death). Average D2 an D3 activ-
ities for the different brain regions are shown in Fig. 5 for
fetuses and premature infants separately. D3 activity was
highest in Cbl, but considerable D3 activities were also found
in MB, BG, BS, SC, and H, whereas D3 activity was low in the
FIG. 4. Comparison of the changes in T3 to T4 ratios in fetal serum, CP, GE, and cortex, as linear functions of PMA. The serum T3/T4 ratio tended
to decrease as a linear function of PMA but did not reach statistical significance (r0.403; P 0.070). The ratios are plotted on a logarithmic
scale to emphasize the differences among these three brain areas and between them and the serum. The functions fitting the CC data were
distinctly different from the others because there was no overlap between the 95% confidence intervals of its positive regression coefficient and
the negative ones of the other two areas. These coefficients did overlap when the CP and GE were compared.
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GE, CP, and CC. In some fetal samples, D3 activities were
higher than in those of the same region obtained from the
premature infants. D2 activities were highest in CP and CC,
in which D3 activities were the lowest. Most D2 activities
ranged between 8 and 20 fmol/hmg protein. Although such
values are about 100 times lower than the D3 activities, they
are similar to, or higher than, those found in normal brain
tissue from adults (18).
Figure 6 shows the D2 activities in different brain areas,
plotted against PMA. D2 activity was detected in all regions
and increased with PMA in the CC and Cbl (P 0.05). After
controlling for PMA and using all data from all regions
throughout the fetal period as a whole, D2 activities were
found to correlate positively with the concentrations of T4
(r  0.65, P  0.001) and rT3 (r  0.42, P  0.001) and
negatively with the T3/T4 ratios in the CC (r  0.29, P 
0.008). Except for the correlation between D2 activities and
T4 concentrations, the statistical significance disappeared
when the data from the premature infants were included.
As shown in Fig. 7, D3 activities decreased with PMA in
Cbl, BS, and SC (P 0.05). At all stages, highest D3 activities
were found in the Cbl. D3 activities were low throughout the
study period in GE, CP, and CC.
Table 3 shows the correlations between the average D3
activities and the iodothyronine levels and ratios in the dif-
ferent brain regions. Figure 8A shows the correlation be-
tween the average D3 activities and the rT3/T3 and rT3/T4
ratios. T4 levels tended to decrease and rT3 levels tended to
increase with D3 activity. A significant negative correlation
was found between D3 activity and the T3 level (r0.682).
D3 activities were positively correlated with the rT3/T3 ratio
(r  0.812, P  0.008) and the rT3/T4 ratio (r  0.889, P 
0.001). Figure 8B depicts the average D3 activities and rT3/T3
and rT3/T4 ratios in the different brain regions. Except for the
CP, the rT3/T3 and rT3/T4 ratios correlated positively with
increasing D3 activities.
The D3 activities shown in Figs. 5, 7, and 8 and in Table
3 were measured in the Rotterdam laboratory. The fewer
determinations performed in the Madrid laboratory with a
different methodology fully supported these findings, in-
cluding the different correlations that have been described
here.
Discussion
Studies using the rat as an animal model have shown that
fetal and neonatal hypothyroidism lead to multiple struc-
tural, functional, and biochemical alterations of brain devel-
opment (see reviews in Refs. 38, 50, 51). These studies, to-
gether with clinical evidence for the effects of maternal
hypothyroxinemia on brain development (for review see Ref.
1), indicate the importance of a tightly regulated thyroid
hormone bioavailability during brain development. Iodo-
thyronine deiodination contributes to this regulation. In this
study we determined local iodothyronine levels and deio-
dinase activities in different brain regions at different stages
of development to evaluate the possible contribution of the
different deiodinases in controlling local T3 availability in the
human developing brain.
As already pointed out previously, it is quite likely that the
changes in the concentrations of T4, T3, and rT3 observed with
the samples of the fetuses from normal mothers reflect the
true ontogenic profile for different areas of the human brain.
They are quite different for the different areas studied and
cannot be predicted from the changes found in the fetal
circulation. Obviously we cannot exclude that there are also
differences within each area related to cellular heterogeneity
and different timing of maturational events in each structure,
but this point cannot yet be adequately resolved with the
sensitivity of presently available techniques. A similar com-
ment might also be pertinent for the D2 and D3 activities here
reported.
The changes found in some areas before midgestation
appear to merit closer attention. The highest T4 and rT3
concentrations were observed in the choroid plexus. T4 in-
creased significantly with PMA, despite little change in the
low T3 concentrations; indeed, the T3/T4 and rT3/T4 ratios
FIG. 5. Average D3 and D2 activities of the different brain regions.
Results are the means  SE of samples from fetuses (13–20 wk PMA)
and premature infants at death (Table 2). Asterisks identify statis-
tically significant differences between the mean values for fetuses vs.
premature infants. D3 activities decreased from Cbl to CP and CC
(CblMBBS SCGECCCP for fetuses; CblBGBS
H  SC  GE  CP  CC for premature infants). D2 activities were
highest in CP, followed by CC (CP  CC  Cbl  SC  MB  BS 
GE for fetuses; CC  Cbl  H  SC  GE  BS  BG for premature
infants). The  sign indicates a statistically significant difference
between areas, whereas the sign indicates that the differences were
not statistically significant.
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were decreasing with PMA. The lack of increase in the con-
centration of T3 is also rather striking when we consider that
the D2 activities were among the highest. This could not be
attributed to high D3 activities because these were very low.
However, it should be realized that the deiodination rates
measured under in vitro conditions may not represent deio-
dination taking place in vivo. It is possible that only a small
proportion of the total T4 we have measured in the choroid
plexus samples is actually available intracellularly for deio-
dination by D2 and D3: most of it is likely to be bound by
FIG. 6. D2 activities in samples from fetuses (E) and premature infants (F) as a function of PMA from CP, CC, Cbl, H, BS, GE, SC, MB, and
BG. For the meaning of r and P values, see the legend to Fig. 2. D2 activities changed with increasing PMA, the CC and Cbl following cubic
functions of PMA, but no well-defined patterns were found in the remaining areas.
FIG. 7. D3 activities in fetuses (E) and premature infants (F) as a function of PMA from Cbl, MB, BG, BS, SC, H, GE, CP, and CC as a function
of PMA. The r values show Pearson’s correlation coefficient with PMA.
3124 J Clin Endocrinol Metab, July 2004, 89(7):3117–3128 Kester et al. • Iodothyronine Deiodination in Human Developing Brain
 by on May 21, 2010 jcem.endojournals.orgDownloaded from 
transthyretin, which is already synthesized in the human CP
long before 13 wk PMA (52). Despite the fact that transport
of T4 from the plasma to the brain is normal in transthyretin-
null mice (53), the CP is considered to be important for the
transport of T4 into the brain. The transthyretin that is syn-
thesized in the CP epithelial cells would either transfer T4
from the epithelial cells to the cerebrospinal fluid or facilitate
its passage after the transthyretin is excreted into the cere-
brospinal fluid (54). The amounts of substrate iodothyroni-
nes actually reaching D2 and D3 deiodination sites may well
be much lower than expected from the total concentrations.
It is therefore likely that in this unique and morphologically
heterogeneous structure mechanisms other than deiodina-
tion, such as thyroid hormone transport, are more important
for the regulation of intracellular thyroid hormone levels.
The largest increase in T3 concentration up to midgestation
was observed in the CC, which appeared to continue even
when the T4 concentrations were no longer increasing. As a
result, the cortex T3/T4 ratio increased throughout this pe-
riod, in contrast to the serum T3/T4 ratio, which tended to
decrease. On the contrary, rT3 concentrations and rT3/T4
ratios were decreasing during the same developmental pe-
riod. Thus, both the changes in T3 and rT3 concentrations
were consistent with the findings that D2 activities were
clearly detectable by 13 wk PMA, and D3 activities were the
lowest found in the present study. We cannot exclude that
other regulatory mechanisms are also involved in determin-
ing the concentration of T3 in the CC. The changes described
here for the CC up to midgestation are consistent with pre-
vious findings by others (8, 16, 17), showing that both T3 and
thyroid hormone receptor concentrations are increasing in
the human brain between 8 and 18 wk PMA: at 13 wk ges-
FIG. 8. Average rT3/T3 and rT3/T4 ratios as a function of D3 activities (A) and average D3 activities and rT3/T3 and rT3/T4 ratios in the different
brain regions (B). Results are the means per brain region  SE. The r value indicates the Pearson’s correlation between D3 activity and the
iodothyronine ratio (B).
TABLE 3. Correlation of D3 activity with iodothyronine levels
and ratios in different brain regions from fetuses and premature
infants
Iodothyronine levels Iodothyronine ratios
rT3 T4 T3 rT3/T4 rT3/T3 T3/T4
r 0.138 0.454 0.682 0.889 0.812 0.236
P 0.723 0.219 0.043 0.001 0.008 0.539
Pearson’s correlation coefficient r and P values were calculated
using SPSS.
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tation T3 concentrations in the cortex had already reached
60% of adult values. D2 and D3 activities have also been
previously reported in the human CC by 11–14 wk PMA (55).
We point out that the present T3 concentrations in the human
CC are comparable with those reported in adults: 1.5–2.2
pmol T3/g (1.0–1.4 ng T3/g) (18, 56). The fetal D2 activities
are actually much higher than reported in the adult cortex
(8 fmol/hmg protein) (18). The ontogenic changes of T4, T3,
and D2 observed in the present study are in conceptual
agreement with those reported for the rat brain (46, 49);
between 18 and 22 d of gestation, there is a 4-fold increase
in D2 activity, a 10-fold increase in T4 concentrations, and an
18-fold increase in T3 concentrations in rat CC.
The present results also indirectly support the hypothesis
that T3 is relevant for the development of the human CC from
very early in gestation, possibly soon after completion of
morphogenesis of the pros-encephalon (57). Although this
hypothesis is supported by epidemiological and clinical find-
ings (1), no direct proof is available for man. It has, however,
been directly confirmed (58) in the rat for a developmental
period corresponding to that occurring in man before mid-
gestation. The tendency of T3 concentrations to increase in
the GE before midgestation suggests that this structure might
already be thyroid hormone sensitive, but we are unaware of
any studies regarding abnormalities in this structure related
to thyroid hormone insufficiency.
The ontogenic changes in the developing human Cbl con-
trast with those described for the CC. The concentrations of
T4 and T3 remained low, and especially T3 was maintained
at levels that were appreciably lower than those found dur-
ing the same period in other areas, such as the cortex, GE, SC,
and even CP. D2 activities were similar to those found in the
cortex, but D3 activities were the highest found in any of the
brain areas studied during this developmental period and
are likely to be a very important factor in the maintenance of
the low cerebellar T3 concentrations. So are the high D3
activities found in MB, BS, and SC, all areas in which T3
concentrations were low during most of the developmental
period up to midgestation.
Some caution should be applied to the interpretation of
data obtained in the postnatal brain samples, insofar as it is
not excluded that they may to some extent be influenced by
nonthyroidal illness, which is known to affect peripheral
thyroid hormone metabolism (59, 60).
The present results confirm for the human developing
brain the same principles that appear to modulate T3 bio-
availability in different developing structures, and in differ-
ent species, in a temporally and spatially specific sequence of
events, namely by the ontogenetically programed expression
of the iodothyronine deiodinase isoenzymes, mainly D2 and
D3 (29, 61, 62). D1 activity was not detected in any brain area.
This is in agreement with previous studies of Campos-Barros
et al. (63), who found D2 and D3 activity, but no D1 activity,
in adult human brain. We have already discussed the D2
activities found in different areas, compared with those in
adults. The activities of D3 during early development that we
report here for different brain areas show very high levels in
specific structures that, in general, tend to decrease with
PMA. The highest D3 activities were found in Cbl and were
higher than in the adult brain (64). The spatial distribution
of D3, however, differs: in the adult brain, D3 activity is low
in Cbl, MB, and BS, whereas higher levels are found in the
H and CC (Visser, T. J., E. Kaptein, and E. Fliers, unpublished
data, and Ref. 64). Santini et al. (64) found that T3 levels are
also negatively correlated with D3 activity in the adult brain,
as described here for the developing human brain.
The D3 activities found here for the brain are only 2-fold
lower than those reported in human placenta (31). D3 ex-
pression in the placenta is believed to protect the fetus from
excessive maternal T3 (12, 15, 28). Thyroid hormone induces
neuronal differentiation such as dendritic and axonal
growth, neuronal migration, and myelination (38). Strict reg-
ulation of thyroid hormone bioavailability is critical because
neuronal development is affected in the hypothyroid and
hyperthyroid brain. The high D3 activities we found in the
brain, which tended to decrease with age, suggest that local
D3 is important to limit T3 in the various brain regions during
critical stages of development. It is unclear whether D3 has
an additional physiological role in the production of rT3 and
3,3-T2. Because rT3, but not T3, has profound and acute
effects on the cytoskeleton in brain cells (65), it is not ex-
cluded that rT3 also has a function in brain development.
3,3-T2 has been shown to increase the basal metabolic rate
in adult rat. This effect may be mediated by direct mito-
chondrial binding (66).
D2 and D3 are expressed in distinct cell types: D2 in as-
trocytes and tanycytes and D3 in neurons. The hypothesis
has been put forward (38) that astrocytes and tanycytes take
up T4 from the circulation and convert it to T3, which is
delivered to neurons (that contain most of the nuclear re-
ceptors), in which D3 would limit T3 availability according
to the local temporal needs for thyroid hormone action. In
addition, although still poorly studied, metabolic pathways
other than deiodination, such as sulfation, may play regu-
latory roles in the developing brain.
A large number of cerebral genes are regulated by thyroid
hormone (38). Although not much is known on the molecular
basis for the specific timing of action on gene expression, it
is known that the different regions of the brain have specific
temporal patterns of development and thus require different
regulation of T3 bioavailability. In general, roughly, the ce-
rebral cortex starts to develop in the second month of preg-
nancy, whereas major events in cerebellar development do
not occur until wk 34 (51). In agreement with this, we found
low D3 activity in the CC, which would require T3 for dif-
ferentiation early in development and high D3 activity in the
later developing Cbl.
In this study, we also compared the average D3 activities
with the average thyroid hormone levels and ratios in the
different brain regions. Except for the CP, we observed that
D3 activity was high in the regions with low T3 and T4 and
high rT3 levels and low in regions with high T3 and T4 and
low rT3 levels. We found a significant negative correlation
between D3 activities and T3 levels and significant positive
correlations between D3 activity and the ratio of rT3/T3 and
the ratio of rT3/T4. Because D3 catalyzes the degradation of
T3 and T4 and the production of rT3, our results suggest that
D3 is also important in humans for the regulation of the
intracellular thyroid hormone levels in the different brain
regions. Furthermore, no D1 activity was found in any brain
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region. In addition to the presence of D3 activity, the absence
of D1 activity may contribute to the high tissue rT3 levels.
In conclusion, by determining and correlating the onto-
genic patterns of deiodinase activities and thyroid hormone
levels in the human brain, we have shown that both D3- and
D2-catalyzed deiodination are important pathways for the
intracellular regulation of thyroid hormone in the different
regions of the developing human brain, this regulation being
region and time specific. Although D3 is expressed to a
greater extent than D2, the latter is clearly important in
thyroid hormone activation at the cellular level. Further in
situ hybridization and immunohistochemistry studies are
required to confirm the hypothesis that a close regulation of
D2 and D3 activities is crucial for tailoring T3 bioavailability
to changing needs of human developing brain structures.
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